Chang David D Insider Trading Activity

Average Profitability
2.3%
Insider Buys Quantity
1
Insider Buys Sum
$1.44M
Insider Sells Quantity
5
Insider Sells Sum
$1.93M

Insider Activity of Chang David D

According to the SEC Form 4 filings, Chang David D, being in a position of

  1. President and CEO at Allogene Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 143032 shares for $289,459,
    over all time since 2018-10-15, has bought 80000 shares for $1.44M, and sold 320534 shares for $2.22M.

Biography of Chang David D

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $289,4592100

Comparison of Insiders on Amount of Buys and Sells

2026-03-16SaleAllogene Therapeutics, Inc.
ALLO
President and CEO
47,763
0.0215%
$2.47$117,975-18.03%
2026-02-02SaleAllogene Therapeutics, Inc.
ALLO
President and CEO
95,269
0.0408%
$1.80$171,484+8.29%
2025-03-14SaleAllogene Therapeutics, Inc.
ALLO
President and CEO
46,668
0.0225%
$1.96$91,469-30.67%
2025-02-03SaleAllogene Therapeutics, Inc.
ALLO
President and CEO
46,003
0.0205%
$1.68$77,285-19.16%
2022-03-15SaleAllogene Therapeutics, Inc.
ALLO
President and CEO
23,648
0.0164%
$7.65$180,879+21.54%
2021-03-15SaleAllogene Therapeutics, Inc.
ALLO
President and CEO
20,513
0.0153%
$38.57$791,271-42.72%
2020-03-16SaleAllogene Therapeutics, Inc.
ALLO
President and CEO
40,670
0.0392%
$19.31$785,230+88.77%
2018-10-15PurchaseAllogene Therapeutics, Inc.
ALLO
President and CEO
80,000
0.1845%
$18.00$1.44M+2.3%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.